54 related articles for article (PubMed ID: 21809997)
1. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
[TBL] [Abstract][Full Text] [Related]
2. Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
Sipos E; Hegyi K; Treszl A; Steiber Z; Mehes G; Dobos N; Fodor K; Olah G; Szekvolgyi L; Schally AV; Halmos G
Oncol Rep; 2017 Apr; 37(4):1927-1934. PubMed ID: 28350068
[TBL] [Abstract][Full Text] [Related]
3. Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation.
Sandinha MT; Farquharson MA; Roberts F
Br J Ophthalmol; 2004 Dec; 88(12):1527-32. PubMed ID: 15548805
[TBL] [Abstract][Full Text] [Related]
4. Uveal melanoma: the inflammatory microenvironment.
Bronkhorst IH; Jager MJ
J Innate Immun; 2012; 4(5-6):454-62. PubMed ID: 22302072
[TBL] [Abstract][Full Text] [Related]
5. Biopsy for molecular risk stratification in uveal melanoma: Yields and molecular characteristics in 119 patients.
Lin V; Chung IY; Toumi E; McKay D; McKenzie J; McKelvie P; Zabih F; Hoffmeister A; Wright D; Ntzaferi A; Wu IJ; Hesson L; Fung A; Lim LA; Wong S; Field A; Earls P; Giblin M; Conway RM; Cherepanoff S
Clin Exp Ophthalmol; 2022 Jan; 50(1):50-61. PubMed ID: 34714583
[TBL] [Abstract][Full Text] [Related]
6. Identification of multiomics map and key biomarkers in uveal melanoma with chromosome 3 loss.
Yong X; Kang T; Li T; Li S; Hu X; Yan X; Zhang F; Zheng J; Yang Q
Ann Med Surg (Lond); 2024 Feb; 86(2):831-841. PubMed ID: 38333293
[TBL] [Abstract][Full Text] [Related]
7. Depression and anxiety in patients with uveal melanoma undergoing curative proton treatment-A prospective study.
Rabsahl C; Boehmer D; Boeker A; Gauger U; Goerling U; Gollrad J
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1780. PubMed ID: 36639921
[TBL] [Abstract][Full Text] [Related]
8. Gene Expression Profiling as an Adjunctive Measure to Guide the Management of Indeterminate, High-Risk Choroidal Melanocytic Lesions: A Pilot Study.
Weis E; Roelofs K; Larocque M; Murtha A
Ocul Oncol Pathol; 2019 Feb; 5(2):102-109. PubMed ID: 30976587
[TBL] [Abstract][Full Text] [Related]
9. [Ocular melanomas : An update].
Kalirai H; Müller PL; Jaehne D; Coupland SE
Pathologe; 2017 Nov; 38(6):491-499. PubMed ID: 29038913
[TBL] [Abstract][Full Text] [Related]
10. PRiMeUM: A Model for Predicting Risk of Metastasis in Uveal Melanoma.
Vaquero-Garcia J; Lalonde E; Ewens KG; Ebrahimzadeh J; Richard-Yutz J; Shields CL; Barrera A; Green CJ; Barash Y; Ganguly A
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4096-4105. PubMed ID: 28828481
[TBL] [Abstract][Full Text] [Related]
11. Gene-expression and in vitro function of mesenchymal stromal cells are affected in juvenile myelomonocytic leukemia.
Calkoen FG; Vervat C; Eising E; Vijfhuizen LS; 't Hoen PB; van den Heuvel-Eibrink MM; Egeler RM; van Tol MJ; Ball LM
Haematologica; 2015 Nov; 100(11):1434-41. PubMed ID: 26294732
[TBL] [Abstract][Full Text] [Related]
12. Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.
Aaberg TM; Cook RW; Oelschlager K; Maetzold D; Rao PK; Mason JO
Clin Ophthalmol; 2014; 8():2449-60. PubMed ID: 25587217
[TBL] [Abstract][Full Text] [Related]
13. Prognostic parameters in uveal melanoma and their association with BAP1 expression.
van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ
Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: a follow-up study.
Schmidt-Pokrzywniak A; Kalbitz S; Kuss O; Jöckel KH; Bornfeld N; Stang A
BMC Ophthalmol; 2014 Apr; 14():42. PubMed ID: 24685257
[TBL] [Abstract][Full Text] [Related]
15. Case report: an atypical peripapillary uveal melanoma.
Lim LA; Miyamoto C; Blanco P; Bakalian S; Burnier MN
BMC Ophthalmol; 2014 Feb; 14():13. PubMed ID: 24490833
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of monosomy 3 in fine needle aspiration biopsy of choroidal melanoma.
Chang MY; Rao NP; Burgess BL; Johnson L; McCannel TA
Mol Vis; 2013; 19():1892-900. PubMed ID: 24049435
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology of uveal melanoma.
Coupland SE; Lake SL; Zeschnigk M; Damato BE
Eye (Lond); 2013 Feb; 27(2):230-42. PubMed ID: 23222563
[TBL] [Abstract][Full Text] [Related]
18. Genetics of primary intraocular tumors.
Nagarkatti-Gude N; Wang Y; Ali MJ; Honavar SG; Jager MJ; Chan CC
Ocul Immunol Inflamm; 2012 Aug; 20(4):244-54. PubMed ID: 22834783
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.
Singh AD; Aronow ME; Sun Y; Bebek G; Saunthararajah Y; Schoenfield LR; Biscotti CV; Tubbs RR; Triozzi PL; Eng C
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3331-9. PubMed ID: 22511634
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
